ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Chemed Corp

Chemed Corp (CXM)

374,00
8,00
(2,19%)
Chiuso 17 Giugno 10:00PM

Chemed Corp (CXM) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-06-09Dr. Andrea R. LindellIndependent Director-1,35k602,55kVendita447,334,58k-22,73%
2026-05-29Mr. George J. WalshIndependent Chairman-500,00218,92kVendita437,833,64k-12,07%
2026-05-08Mr. Patrick P. GraceIndependent Director-60,0025,55kVendita425,783,34k-1,77%
2026-05-01Mr. Kevin J. McNamaraCEO, President & Director-2,00k842,26kVendita421,1390,22k-2,17%
2026-03-27Mr. Kevin J. McNamaraCEO, President & Director-1,50k554,06kVendita369,3792,22k-1,60%
2026-03-12Mr. Kevin J. McNamaraCEO, President & Director-2,00k806,36kVendita403,1893,72k-2,09%
2026-02-13Mr. Spencer S. LeeExec. VP345,00162,00kDerivative Exercise and Retained Stock469,5614,91k2,37%
2026-02-13Mr. Spencer S. LeeExec. VP-154,000,00Derivative Exercise and Sale469,5614,91k-
2026-02-13Mr. Thomas C. HuttonVP & Director127,0059,63kDerivative Exercise and Retained Stock469,5679,96k0,16%
2026-02-13Mr. Thomas C. HuttonVP & Director-72,000,00Derivative Exercise and Sale469,5679,96k-
2026-02-13Mr. Joel L. WherleyExec. VP and President & CEO of VITAS Healthcare193,0090,63kDerivative Exercise and Retained Stock469,56852,0029,29%
2026-02-13Mr. Joel L. WherleyExec. VP and President & CEO of VITAS Healthcare-80,000,00Derivative Exercise and Sale469,56852,00-
2026-02-13Mr. Michael D. WitzemanExec. VP, Controller, Principal Accounting Officer & CFO293,00137,58kDerivative Exercise and Retained Stock469,565,95k5,18%
2026-02-13Mr. Michael D. WitzemanExec. VP, Controller, Principal Accounting Officer & CFO-120,000,00Derivative Exercise and Sale469,565,95k-
2026-02-13Mr. Kevin J. McNamaraCEO, President & Director1,52k714,67kDerivative Exercise and Retained Stock469,5695,72k1,62%
2026-02-13Mr. Kevin J. McNamaraCEO, President & Director-1,19k0,00Derivative Exercise and Sale469,5695,72k-
2026-02-13Mr. Brian C. JudkinsVP, Secretary & Chief Legal Officer249,00116,92kDerivative Exercise and Retained Stock469,562,44k11,39%
2026-02-13Mr. Brian C. JudkinsVP, Secretary & Chief Legal Officer-102,000,00Derivative Exercise and Sale469,562,44k-
2025-12-26Dr. Andrea R. LindellIndependent Director-463,000,00Other Disposition-5,54k-7,71%
2025-11-24Mr. Kevin J. McNamaraCEO, President & Director-2,00k875,10kVendita437,5594,20k-2,08%
2025-11-19Mr. Spencer S. LeeExec. VP-60,000,00Other Disposition-14,57k-0,41%
2025-09-26Mr. Kevin J. McNamaraCEO, President & Director-3,00k1,38MVendita461,2896,20k-3,02%
2025-09-09Mr. Patrick P. GraceIndependent Director-150,0069,51kVendita463,393,40k-4,23%
2025-08-05Mr. Kevin J. McNamaraCEO, President & Director-2,00k857,10kVendita428,5599,20k-1,98%
2025-08-04Mr. George J. WalshIndependent Chairman200,0083,42kAcquisto417,103,96k5,32%
2025-08-04Mr. Nicholas Michael WestfallInsider-10,01k4,22MVendita421,910,00-100,00%

La tua Cronologia

Delayed Upgrade Clock